Follow the Nectar Lifesciences Limited stock price and the full management transaction log of the company, a listed issuer based in India. Shares are listed on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Nectar Lifesciences Limited has published 11 reports. Market capitalisation: €2bn. The latest transaction was reported on 27 November 2025 (Sale). Among the most active insiders: Sanjiv Goyal. All data is accessible without an account.
11
Insider Decl.
n/a
Thresholds
€201,813
2 ops.
Buy Volume
n/a
1 ops.
Sell Volume
21Σ signal
Buys €201,813n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,840 of 29,063 companies
6.6
score / 100
Value
0
Quality
13
FCF yld-183%
Earn yld-148%
EV/EBITDA·
ROE-7.5%
Gross mgn8.3%
Net mgn-18%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.